Hindcon Chemicals Limited (NSE:HINDCON)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	1,703	1,997	607	534	187	84
Market Cap Growth	2.80%	228.81%	13.72%	185.83%	121.36%	-50.45%
Enterprise Value	1,610	1,904	608	518	161	70
Last Close Price	33.26	51.95	15.74	13.69	4.61	1.99
PE Ratio	25.35	32.31	14.06	12.62	3.95	2.97
PS Ratio	3.07	3.10	0.71	0.80	0.42	0.19
PB Ratio	3.17	3.95	1.42	1.35	0.53	0.26
P/TBV Ratio	3.21	4.00	1.43	1.36	0.53	0.26
P/FCF Ratio	-	36.04	15.80	-	4.32	4.46
P/OCF Ratio	-	21.75	11.31	-	3.91	3.99
EV/Sales Ratio	2.90	2.95	0.71	0.78	0.37	0.16
EV/EBITDA Ratio	34.64	26.83	10.87	10.36	3.59	1.94
EV/EBIT Ratio	37.93	28.24	11.46	10.92	3.74	2.02
EV/FCF Ratio	-	34.37	15.82	-	3.73	3.70
Debt / Equity Ratio	0.01	-	0.02	0.03	0.03	0.01
Debt / EBITDA Ratio	0.13	-	0.18	0.25	0.22	0.10
Debt / FCF Ratio	-	-	0.26	-	0.23	0.19
Asset Turnover	-	1.14	1.61	1.39	1.07	1.17
Inventory Turnover	-	19.16	20.27	19.18	16.45	13.92
Quick Ratio	-	3.92	3.52	2.47	3.82	3.55
Current Ratio	-	4.95	4.56	3.57	4.82	5.10
Return on Equity (ROE)	-	13.35%	10.57%	11.37%	14.04%	9.10%
Return on Assets (ROA)	-	7.45%	6.24%	6.19%	6.52%	5.72%
Return on Capital (ROIC)	5.20%	8.93%	7.83%	7.68%	7.78%	6.83%
Return on Capital Employed (ROCE)	-	13.30%	12.30%	12.00%	12.20%	10.50%
Earnings Yield	2.96%	3.09%	7.11%	7.92%	25.34%	33.69%
FCF Yield	-	2.77%	6.33%	-9.34%	23.14%	22.41%
Dividend Yield	0.59%	0.39%	-	2.48%	6.51%	9.04%
Payout Ratio	-	6.26%	12.43%	45.55%	14.59%	16.19%
Buyback Yield / Dilution	0.28%	-	-	-	-	-
Total Shareholder Return	0.85%	0.39%	-	2.48%	6.51%	9.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.